New cancer clinical trial: PCM-075 in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer

Published on: January 29, 2018 at 12:00PM
Condition:   Metastatic Castration-Resistant Prostate Cancer
Interventions:   Drug: PCM-075;   Drug: Abiraterone;   Drug: Prednisone
Sponsor:   Trovagene, Inc.
Not yet recruiting
http://ift.tt/2BCUkTv